loading
Precedente Chiudi:
$4.82
Aprire:
$4.85
Volume 24 ore:
250.27K
Relative Volume:
0.15
Capitalizzazione di mercato:
$656.74M
Reddito:
$288.95M
Utile/perdita netta:
$-119.03M
Rapporto P/E:
8.5338
EPS:
0.5695
Flusso di cassa netto:
$60.67M
1 W Prestazione:
-6.92%
1M Prestazione:
-43.06%
6M Prestazione:
-55.80%
1 anno Prestazione:
-1.83%
Intervallo 1D:
Value
$4.745
$4.90
Intervallo di 1 settimana:
Value
$4.275
$5.365
Portata 52W:
Value
$4.275
$11.55

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name
Nome
Maravai Lifesciences Holdings Inc
Name
Telefono
(858) 546-0004
Name
Indirizzo
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Name
Dipendente
580
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
MRVI's Discussions on Twitter

Confronta MRVI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
MRVI 4.85 656.74M 288.95M -119.03M 60.67M 0.5695
VRTX 446.61 115.74B 10.63B -479.80M -1.35B 13.33
REGN 740.52 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 592.00 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.85 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.42 24.49B 3.30B -501.07M 1.03B 11.54

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-08-08 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2023-05-23 Downgrade Credit Suisse Outperform → Neutral
2023-05-09 Downgrade Goldman Buy → Neutral
2023-01-05 Downgrade UBS Buy → Neutral
2022-12-14 Iniziato Deutsche Bank Buy
2022-12-07 Iniziato RBC Capital Mkts Outperform
2022-11-03 Downgrade BofA Securities Buy → Neutral
2022-08-25 Iniziato Credit Suisse Outperform
2021-08-05 Ripresa Credit Suisse Outperform
2020-12-16 Iniziato KeyBanc Capital Markets Overweight
2020-12-15 Iniziato BofA Securities Buy
2020-12-15 Iniziato Credit Suisse Outperform
2020-12-15 Iniziato Goldman Buy
2020-12-15 Iniziato Jefferies Buy
2020-12-15 Iniziato Robert W. Baird Outperform
2020-12-15 Iniziato Stifel Buy
2020-12-15 Iniziato William Blair Outperform
2020-12-14 Iniziato UBS Buy
Mostra tutto

Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie

pulisher
Nov 20, 2024

Wolfe Research Initiates Coverage of Maravai LifeSciences Holdings (MRVI) with Peer Perform Recommendation - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

What Do Analysts Think About Maravai LifeSciences Holdings Inc’s (NASDAQ:MRVI) Future? - Stocks Register

Nov 18, 2024
pulisher
Nov 18, 2024

Royce & Associates LP Increases Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

Maravai LifeSciences (NASDAQ:MRVI) Trading Down 7.5%Here's What Happened - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

(MRVI) Trading Report - Stock Traders Daily

Nov 16, 2024
pulisher
Nov 15, 2024

Maravai Lifesciences stock hits 52-week low at $4.68 - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

Steven Cohen's Strategic Acquisition in Maravai LifeSciences - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Maravai LifeSciences shares initiated with Peerperform on positive aspects - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

Maravai lifesci director John DeFord acquires $100,625 in stock - Investing.com

Nov 15, 2024
pulisher
Nov 14, 2024

Insider Buying: Director John Deford Acquires Shares of Maravai LifeSciences Holdings Inc (MRVI) - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Maravai LifeSciences shares initiated with Peerperform on positive aspects By Investing.com - Investing.com Canada

Nov 14, 2024
pulisher
Nov 14, 2024

Maravai LifeSciences (NASDAQ:MRVI) Now Covered by Wolfe Research - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI) - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

12 West Capital Management LP's Strategic Acquisition in Maravai LifeSciences Holdings Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Up Following Insider Buying Activity - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Maravai LifeSciences Announces November 2024 Investor Conference Schedule - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Earnings call: Maravai LifeSciences reports mixed Q3 results, eyes growth - Investing.com India

Nov 12, 2024
pulisher
Nov 12, 2024

Maravai LifeSciences (NASDAQ:MRVI) Price Target Cut to $13.00 by Analysts at Royal Bank of Canada - Defense World

Nov 12, 2024
pulisher
Nov 11, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024
pulisher
Nov 11, 2024

Slammed 37% Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Screens Well Here But There Might Be A Catch - Simply Wall St

Nov 11, 2024
pulisher
Nov 10, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

Nov 10, 2024
pulisher
Nov 09, 2024

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down on Analyst Downgrade - Defense World

Nov 09, 2024
pulisher
Nov 09, 2024

Maravai Lifesciences price target lowered to $9 from $10 at Baird - Yahoo Finance

Nov 09, 2024
pulisher
Nov 08, 2024

Health Care Up on Another Round of Mixed Earnings -- Health Care Roundup - Marketscreener.com

Nov 08, 2024
pulisher
Nov 08, 2024

Royal Bank of Canada Has Lowered Expectations for Maravai LifeSciences (NASDAQ:MRVI) Stock Price - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Maravai LifeSciences stock plunges 39% amid lowered revenue forecast - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Maravai LifeSciences stock plunges 39% amid lowered revenue forecast (NASDAQ:MRVI) - Seeking Alpha

Nov 08, 2024
pulisher
Nov 08, 2024

U.S. Stock market: Evolent Health(-43.35%), Maravai LifeSciences(-38.65%), and Chanson International(-38.04%) in midday trading - Business Upturn

Nov 08, 2024
pulisher
Nov 08, 2024

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down Following Analyst Downgrade - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

U.S. Stock market: Evolent Health (-41.07%), Maravai LifeSciences(-34.44%), Revance Therapeutics(-32.01%) as top losers during early trading - Business Upturn

Nov 08, 2024
pulisher
Nov 08, 2024

Maravai LifeSciences (NASDAQ:MRVI) Given New $9.00 Price Target at Robert W. Baird - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Maravai LifeSciences' (MRVI) Market Perform Rating Reaffirmed at William Blair - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Decoding 5 Analyst Evaluations For Maravai LifeSciences - Benzinga

Nov 08, 2024
pulisher
Nov 08, 2024

Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript - AOL

Nov 08, 2024
pulisher
Nov 08, 2024

Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... By GuruFocus - Investing.com Canada

Nov 08, 2024
pulisher
Nov 08, 2024

Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research - BioSpace

Nov 08, 2024
pulisher
Nov 08, 2024

Maravai LifeSciences Reports Q3 Earnings and Strategic Acquisition - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Maravai LifeSciences stock plunges on weak Q3 results, lowered guidance By Investing.com - Investing.com South Africa

Nov 07, 2024
pulisher
Nov 07, 2024

Maravai LifeSciences stock plunges on weak Q3 results, lowered guidance - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Maravai Lifesciences earnings missed by $0.01, revenue fell short of estimates - Investing.com UK

Nov 07, 2024
pulisher
Nov 07, 2024

Maravai to acquire Officinae Bio's DNA, RNA business By Investing.com - Investing.com South Africa

Nov 07, 2024
pulisher
Nov 07, 2024

Maravai LifeSciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Maravai LifeSciences Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Maravai LifeSciences Holdings Inc (MRVI) Recovers 77.65% From Low: Are We There Yet? - Stocks Register

Nov 07, 2024
pulisher
Nov 05, 2024

Maravai LifeSciences Holdings (STU:MAR) Growth Rank : 8 (As of Nov. 05, 2024) - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

(MRVI) Investment Analysis and Advice - Stock Traders Daily

Nov 05, 2024
pulisher
Nov 05, 2024

Maravai LifeSciences Holdings (STU:MAR) GF Value Rank : 9 (As of Nov. 05, 2024) - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

MRVI Stock Surges Amid Biotechnology Sector Fluctuations - GuruFocus.com

Nov 04, 2024
pulisher
Nov 03, 2024

Cannon Global Investment Management LLC Makes New $590,000 Investment in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Nov 03, 2024
pulisher
Oct 31, 2024

Roubaix Capital LLC Trims Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Oct 31, 2024

Maravai Lifesciences Holdings Inc Azioni (MRVI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Maravai Lifesciences Holdings Inc Azioni (MRVI) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
HULL CARL
See Remarks
Nov 11 '24
Buy
5.64
175,000
987,000
175,000
GTCR INVESTMENT XI LLC
Director
May 28 '24
Sale
9.81
9,940,974
97,570,660
20,150,005
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):